<HTML>
<!-- Edgar-valid HTML by InstantEDGAR(TM) - Copyright Advanced Computer Innovations, Inc., 2014-2015 - Validation: OK -->
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY>
<DIV style='margin-left:0pt;width:468pt'>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>UNITED STATES</FONT><BR><FONT style='font-size:11.5pt'>SECURITIES AND EXCHANGE COMMISSION</FONT><BR><FONT style='font-size:11.5pt'>Washington, D.C. 20549</FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:12pt'><B>FORM 8-K</B></FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'><font style='font-size:11pt;'>&nbsp;</font></P>
<P align=center style='font-family:"Times New Roman";margin:0'><font style='font-size:11pt;'>&nbsp;</font></P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'>Date of Report (Date of earliest event reported): &#160;&#160;&#160;&#160;November 6, 2015</FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:14pt'><B><U>VITRO DIAGNOSTICS, INC.</U></B></FONT><BR><FONT style='font-size:9pt'>(Exact Name of Registrant as Specified in its Charter)</FONT></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:9pt;'>&nbsp;</font></P>
<P style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<TABLE align='center' style='border-collapse:collapse'><TR><TD valign='top' style='width:170.95pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'><U>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nevada&#160;&#160;&#160;&#160;&#160;&#160;&#160;</U></FONT></P></TD><TD valign='top' style='width:126.05pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'><U>&#160;&#160;&#160;&#160;&#160;&#160;&#160;0-17378&#160;&#160;&#160;&#160;&#160;&#160;&#160;</U></FONT></P></TD><TD valign='top' style='width:139.5pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'><U>&#160;&#160;&#160;&#160;84-1012042&#160;&#160;&#160;&#160;</U></FONT></P></TD></TR>
<TR><TD valign='top' style='width:170.95pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:9pt'>(State or other jurisdiction</FONT><BR><FONT style='font-size:9pt'> of incorporation)</FONT></P></TD><TD valign='top' style='width:126.05pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:9pt'>Commission File</FONT><BR><FONT style='font-size:9pt'>Number</FONT></P></TD><TD valign='top' style='width:139.5pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:9pt'>(I.R.S. Employer Identification number)</FONT></P></TD></TR>
</TABLE><P style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'><U>4621 Technology Drive, Golden CO &nbsp;80403</U></FONT><BR><FONT style='font-size:9pt'>(Address of principal executive offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Zip Code)</FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'><font style='font-size:8pt;'>&nbsp;</font></P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11pt'>Registrant's telephone number, including area code:&#160;&#160;&#160;<U>(303) 999-2130</U></FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'><font style='font-size:9pt;'>&nbsp;</font></P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:9pt'>______________________________________________________</FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'><FONT style='font-size:9pt'>(Former name or former address, if changed since last report)</FONT></P>
<P align=center style='font-family:"Times New Roman";margin:0'><font style='font-size:9pt;'>&nbsp;</font></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<TABLE style='border-collapse:collapse'><TR><TD valign='top' style='width:41.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>___</FONT></P></TD><TD valign='top' style='width:437.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>Written communications pursuant to Rule 425 under the Securities Act </FONT></P></TD></TR>
<TR><TD valign='top' style='width:41.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>___</FONT></P></TD><TD valign='top' style='width:437.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act</FONT></P></TD></TR>
<TR><TD valign='top' style='width:41.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>___</FONT></P></TD><TD valign='top' style='width:437.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act</FONT></P></TD></TR>
<TR><TD valign='top' style='width:41.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>___</FONT></P></TD><TD valign='top' style='width:437.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act</FONT></P></TD></TR>
</TABLE><P style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:9pt;'>&nbsp;</font></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:9pt;'>&nbsp;</font></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<TABLE style='border-collapse:collapse;width:498.8pt'></TABLE><HR style='page-break-after:always' size=5 color='#000000'>
<TABLE style='border-collapse:collapse;width:498.8pt'><TR><TD valign='top' style='width:90.9pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><B><U>ITEM 5.02</U></B></FONT></P></TD><TD valign='top' style='width:407.9pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><B><U>DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION</U></B></FONT></P></TD></TR>
<TR><TD valign='top' style='width:90.9pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:407.9pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><B><U>OF DIRECTOR; APPOINTMENT OF CERTAIN OFFICERS;</U></B></FONT></P><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><B><U>COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS</U></B></FONT></P><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD></TR>
</TABLE><P align=justify style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<P align=justify style='font-family:"Times New Roman";margin:0'><kbd style='width:36pt;float:left;margin-bottom:-3px;font-family:"Times New Roman"'>&nbsp;</kbd><FONT style='font-size:12pt'>On November 27, 2015, Jeff Liter voluntarily tendered his resignation as a member of the Board of Directors of Vitro Diagnostics, Inc. &nbsp;The resignation was effective November 6, 2015.</FONT></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:12pt;'>&nbsp;</font></P>
<P style='font-family:"Times New Roman";margin:0'><kbd style='width:72pt;float:left;margin-bottom:-3px;font-family:"Times New Roman"'><FONT style='font-size:11.5pt'><B><U>ITEM 3.02</U></B></FONT></kbd><FONT style='font-size:11.5pt'><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SALE OF UNREGISTERED SECURITIES</U></B></FONT></P>
<P align=center style='font:12pt Times New Roman;margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<P align=justify style='font:12pt Times New Roman;margin:0'><kbd style='width:36pt;float:left;margin-bottom:-3px;font-family:"Times New Roman"'>&nbsp;</kbd><FONT style='font-size:11.5pt'>On November 30, 2015, the Company issued a 6% unsecured convertible promissory note in the principal amount of $36,288 in favor of Clifford Neuman representing accrued and unpaid fees for legal services rendered for the Company. &nbsp;The note is due on 30 days&#8217; demand and is convertible, at the option of the holder, into shares of the Company&#8217;s common stock at a conversion price of $0.04 per share, which was the closing price of the Company&#8217;s common stock on the over-the-counter market on November 4, 2014, the date when the terms of the note were agreed upon.</FONT></P>
<P align=center style='font:12pt Times New Roman;margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<P align=center style='font:12pt Times New Roman;margin:0'><FONT style='font-size:11.5pt'> </FONT><font style='font-size:11.5pt;'>&nbsp;</font></P>
<P align=center style='font:12pt Times New Roman;margin:0'><FONT style='font-size:11.5pt'><B>SIGNATURES</B></FONT></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<P align=justify style='font-family:"Times New Roman";margin:0'><kbd style='width:36pt;float:left;margin-bottom:-3px;font-family:"Times New Roman"'>&nbsp;</kbd><FONT style='font-size:11.5pt'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</FONT></P>
<P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P>
<TABLE style='border-collapse:collapse'><TR><TD valign='top' style='width:32.4pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:207pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD colspan='2' valign='top' style='width:239.4pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><B>Vitro Diagnostics, Inc. </B></FONT><BR><FONT style='font-size:11.5pt'>(Registrant)</FONT></P></TD></TR>
<TR style='height:20.25pt'><TD valign='top' style='width:32.4pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:207pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:13.5pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:225.9pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD></TR>
<TR style='height:27pt'><TD valign='top' style='width:32.4pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:207pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>Dated:<U>&#160;November 30, 2015</U></FONT></P></TD><TD valign='top' style='width:13.5pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:225.9pt'><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'><U>__</U><I>/s/</I><U><I>James R. Musick</I></U></FONT></P><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>James R. Musick, President</FONT></P><P style='font-family:"Times New Roman";margin:0'><FONT style='font-size:11.5pt'>and Chief Executive Officer</FONT></P></TD></TR>
<TR style='height:27pt'><TD valign='top' style='width:32.4pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:207pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:13.5pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD><TD valign='top' style='width:225.9pt'><P style='font-family:"Times New Roman";margin:0'><font style='font-size:11.5pt;'>&nbsp;</font></P></TD></TR>
</TABLE><P style='font-family:"Times New Roman";margin:0'>&nbsp;</P>
<P align=center style='font-family:"Times New Roman";margin:0'>2&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "vd_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 13745}]
{"company-data": {"conformed-name": "VITRO DIAGNOSTICS INC", "cik": "0000793171", "assigned-sic": "2836", "irs-number": "841012042", "state-of-incorporation": "NV", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-17378", "film-number": "151273226"}, "business-address": {"street1": "4621 TECHNOLOGY DRIVE", "city": "GOLDEN", "state": "CO", "zip": "80403", "phone": "(720) 859-4120"}, "mail-address": {"street1": "4621 TECHNOLOGY DRIVE", "city": "GOLDEN", "state": "CO", "zip": "80403"}, "former-company": [{"former-conformed-name": "LABTEK INC", "date-changed": "19870217"}, {"former-conformed-name": "IMPERIAL MANAGEMENT INC", "date-changed": "19870201"}]}
Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):     November 6, 2015
VITRO DIAGNOSTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Nevada
0-17378
84-1012042
(State or other jurisdiction
of incorporation)
Commission File
Number
(I.R.S. Employer Identification number)
4621 Technology Drive, Golden CO  80403
(Address of principal executive offices)                    (Zip Code)
Registrant's telephone number, including area code:
(303) 999-2130
______________________________________________________
(Former name or former address, if changed since last report)
___
Written communications pursuant to Rule 425 under the Securities Act
___
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
___
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
___
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
ITEM 5.02
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION
OF DIRECTOR; APPOINTMENT OF CERTAIN OFFICERS;
COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
On November 27, 2015, Jeff Liter voluntarily tendered his resignation as a member of the Board of Directors of Vitro Diagnostics, Inc.  The resignation was effective November 6, 2015.
ITEM 3.02
SALE OF UNREGISTERED SECURITIES
On November 30, 2015, the Company issued a 6% unsecured convertible promissory note in the principal amount of $36,288 in favor of Clifford Neuman representing accrued and unpaid fees for legal services rendered for the Company.  The note is due on 30 days' demand and is convertible, at the option of the holder, into shares of the Company's common stock at a conversion price of $0.04 per share, which was the closing price of the Company's common stock on the over-the-counter market on November 4, 2014, the date when the terms of the note were agreed upon.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Vitro Diagnostics, Inc.
(Registrant)
Dated:
November 30, 2015
__
/s/
James R. Musick
James R. Musick, President
and Chief Executive Officer
2